Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
Active, not recruiting · NCT03900884 · Registry updated 2024-11-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer | Breast Neoplasm Female | Active, not recruiting | Phase 1 | 2024-11-07 | NCT03900884 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peter MacCallum Cancer Centre, Australia | 48 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Austin Health | Melbourne | Australia | 16 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 149 |
| Royal Melbourne Hospital | Melbourne | Australia | 7 |